Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Vegetarians less likely to develop cancer than meat eaters

Vegetarians less likely to develop cancer than meat eaters

First report on cancer incidence and ethnicity

First report on cancer incidence and ethnicity

Certain pesticides double the risk of blood disorder

Certain pesticides double the risk of blood disorder

Formaldehyde exposure among industrial workers linked to greater risk of cancers of the blood and lymphatic system

Formaldehyde exposure among industrial workers linked to greater risk of cancers of the blood and lymphatic system

X-rays help predict permanent bone damage from bisphosphonates

X-rays help predict permanent bone damage from bisphosphonates

Protein FGFR3 a potential therapeutic target for several cancers

Protein FGFR3 a potential therapeutic target for several cancers

Discovery of gene that protects against leukemia

Discovery of gene that protects against leukemia

Novel hemodialysis procedure improves health of cancer patients

Novel hemodialysis procedure improves health of cancer patients

Discovery of new cancer gene

Discovery of new cancer gene

Small molecules block cancer gene

Small molecules block cancer gene

Proepithelin encourages cell growth and migration in prostate cancer

Proepithelin encourages cell growth and migration in prostate cancer

Trial of Quadramet (153 Samarium-lexidronam) in combo with Velcade shows positive results

Trial of Quadramet (153 Samarium-lexidronam) in combo with Velcade shows positive results

New drug short-circuits cancer growth

New drug short-circuits cancer growth

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Stress may speed growth of melanoma tumors

Stress may speed growth of melanoma tumors

Virotherapy treatment kills prostate cancer cells

Virotherapy treatment kills prostate cancer cells

Sun Pharmaceutical receives FDA approvals for 4 generics

Sun Pharmaceutical receives FDA approvals for 4 generics

Cylene Pharmaceuticals starts CX-4945 trial - first-in class inhibitor of CK2

Cylene Pharmaceuticals starts CX-4945 trial - first-in class inhibitor of CK2

New therapy for transplant rejection

New therapy for transplant rejection

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas